Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2018-09-12 | 2019-08-06 | 61349 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-01-09 | 2020-06-25 | 102890 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-05-21 | 2020-06-04 | 115544 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120899 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-08-13 | 2020-10-08 | 122194 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-12-03 | 2021-01-14 | 129515 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132267 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2021-03-25 | 2021-09-16 | 136283 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142619 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160989 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-02-02 | 2023-07-12 | 183395 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2023-02-09 | 2023-06-09 | 184198 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
ACT ENALAPRIL | 16MG | TABLET | Resolved | 2023-06-19 | 2023-07-06 | 195646 |
TEVA-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-02-22 | 2024-05-23 | 220267 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 0.5G | POWDER FOR SOLUTION | Discontinued | 2019-08-08 | 2019-08-08 | 91175 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Discontinued | 2020-07-10 | 2020-07-10 | 120021 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97243 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2019-10-25 | 2019-10-26 | 97261 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65036 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |